Mubadala Investment Co PJSCMubadala Investment Co PJSC

Institutional investor · Portfolio as of Q3 2024

Top Holdings14 positions

Checking export access…
Activity:

GLOBALFOUNDRIES INC ORDINARY SHARES

450.4M$18.1B96.3%$60.60-32.43%
4 qtrssince 2023-Q4
Decreased
0
ARMARM
ADR

Arm Holdings PLC

1.5M$214.8M1.1%$75.14+93.75%
4 qtrssince 2023-Q4
Unchanged
0

CERTARA INC COM

9.6M$112.6M0.6%$17.59-48.10%
4 qtrssince 2023-Q4
Unchanged
0

RECURSION PHARMACEUTICALS INC CL A

13M$85.6M0.5%$9.86-29.21%
4 qtrssince 2023-Q4
Unchanged
0

ARIS MINING CORPORATION COM

15.8M$72.5M0.4%$5.17+21.08%
2 qtrssince 2024-Q2
Unchanged
0

NEXTDECADE CORP COM

14.2M$66.9M0.4%$4.77+0.63%
4 qtrssince 2023-Q4
Unchanged
0
EDEDRDelisted

ENDEAVOR GROUP HLDGS INC

2.2M$63.8M0.3%——
4 qtrssince 2023-Q4
Unchanged
0
TWKSTWKSDelisted

TURING HOLDING CORP

7.8M$34.4M0.2%——
4 qtrssince 2023-Q4
Unchanged
0

COUPANG INC CL A

1M$24.6M0.1%$16.19-2.29%
4 qtrssince 2023-Q4
Decreased
0
EVOEVO
ADR

EVOTEC AG SPONSORED ADS

4.6M$16.8M0.1%$11.73-69.57%
4 qtrssince 2023-Q4
Unchanged
0

YANDEX N V

539,751$10.2M0.1%——
4 qtrssince 2023-Q4
Unchanged
0

OUTSET MED INC

1.4M$975,2870.0%———
Unchanged
0
EVEVVAQDelisted

ENVIVA INC

472,529$191,2800.0%——
4 qtrssince 2023-Q4
Unchanged
0
??GDEV INC
Warrant
2.2M$110,9990.0%——
4 qtrssince 2023-Q4
Unchanged
0
$18.8B
AUM
14
Positions
Q3 2024
Filing
HI score · 2.0/5
Quarterly 13F Value Change
-14%Q1'24$25.5B-3%Q2'24$24.7B-24%Q3'24$18.8B
Activity profile
$ moved · Q3'24
New0%Increased0%Decreased97%Exited3%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.9 quarters
<1Q0%1-4Q100%1-2Y0%2Y+0%

Mubadala Investment Co PJSC manages $18.8B across 14 positions as of Q3 2024. Top holdings: GFS (96.3%), ARM (1.1%), CERT (0.6%). Fund DNA: Momentum Trader. HoldingsIntel Score: 2/5.0.

Q3 2024 Summary

Exited 5, trimmed 2. No standout high-conviction moves this quarter. Portfolio: $18.8B across 14 positions.

Top holdings by portfolio weight

Total AUM$19B
GFS96.27%
ARM1.14%
CERT0.60%
RXRX0.45%
ARMN0.38%
NEXT0.36%
EDR0.34%
TWKS0.18%
CPNG0.13%
EVO0.09%
Other0.05%

Portfolio allocation by GICS sector

Sectors6
Technology97.41%
Healthcare1.15%
Unknown0.91%
Energy0.36%
Consumer Cyclical0.13%
Communication Services0.05%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(2.0 / 5.0)
Holdings P&L53
Conviction36
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
3Q
CICICIGNA CORP NEW
Q4 2025 → Q2 2026+33,218 shares+$9M
2Q
ABBVABBVAbbVie Inc.
Q1 2026 → Q2 2026+3,086 shares+$1.2M
2Q
BCOBCOBRINKS CO COM
Q1 2026 → Q2 2026+5,277 shares-$13,074
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used